http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003149284-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y02P20-55 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D305-14 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D305-14 |
filingDate | 2002-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_780c7fb097dedbb8fde94f58d8c8189b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59f72f7f4213ae1b9002c91e3d8da147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f9f589e0ef7139e123d6fef8c5797e8b |
publicationDate | 2003-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2003149284-A1 |
titleOfInvention | Method of synthesizing a paclitaxel derivative |
abstract | A process for synthesizing paclitaxel derivative compounds useful for the treatment of cancer, comprises protecting the hydroxyl group at C-2′ position of a paclitaxel compound by reacting the same with a protecting group reagent to provide a protecting group (PG) at the C-2′ position, converting the hydroxyl group at C-7 position of the paclitaxel compound to a methylthiomethyl ether, and deprotecting the C-2′ position hydroxyl group through the removal of the protecting group reagent, thus yielding the final desired paclitaxel derivative product. |
priorityDate | 2001-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 151.